Insider Transactions in Q1 2022 at Incyte Corp (INCY)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2022
|
Paul J Clancy Director |
BUY
Grant, award, or other acquisition
|
Direct |
326
+3.78%
|
$25,754
$79.42 P/Share
|
|
Mar 31
2022
|
Wendy L Dixon Director |
BUY
Grant, award, or other acquisition
|
Direct |
249
+1.38%
|
$19,671
$79.42 P/Share
|
|
Mar 31
2022
|
Edmund Harrigan Director |
BUY
Grant, award, or other acquisition
|
Direct |
240
+4.13%
|
$18,960
$79.42 P/Share
|
|
Mar 31
2022
|
Jacqualyn A Fouse Director |
BUY
Grant, award, or other acquisition
|
Direct |
280
+3.19%
|
$22,120
$79.42 P/Share
|
|
Mar 31
2022
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
880
+0.01%
|
-
|
|
Mar 10
2022
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
218,563
+0.19%
|
$15,736,536
$72.39 P/Share
|
|
Mar 09
2022
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
70,517
+0.19%
|
$5,006,707
$71.72 P/Share
|
|
Mar 08
2022
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
100,000
+0.27%
|
$7,000,000
$70.67 P/Share
|
|
Mar 08
2022
|
Baker Bros. Advisors LP |
BUY
Exercise of conversion of derivative security
|
Indirect |
40,000
+0.37%
|
$880,000
$22.05 P/Share
|
|
Feb 22
2022
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
99,800
+0.27%
|
$6,786,400
$68.07 P/Share
|
|
Feb 18
2022
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
133,032
+0.18%
|
$9,046,176
$68.4 P/Share
|
|
Feb 17
2022
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
292,972
+0.44%
|
$19,629,124
$67.56 P/Share
|
|
Feb 14
2022
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
502,852
+0.77%
|
$33,188,232
$66.03 P/Share
|
|
Feb 11
2022
|
Christiana Stamoulis EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,177
-1.03%
|
$77,682
$66.76 P/Share
|
|
Feb 11
2022
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
276,507
+0.43%
|
$18,249,462
$66.88 P/Share
|
|
Feb 10
2022
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
819,015
+0.84%
|
$54,874,005
$67.1 P/Share
|
|
Jan 31
2022
|
Jonathan Elliott Dickinson EVP, General Manager, Europe |
SELL
Open market or private sale
|
Direct |
7,375
-19.62%
|
$545,750
$74.19 P/Share
|
|
Jan 24
2022
|
Jonathan Elliott Dickinson EVP, General Manager, Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
78
-0.21%
|
$5,850
$75.34 P/Share
|
|
Jan 24
2022
|
Michael James Morrissey EVP, Head of Tech. Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
78
-0.14%
|
$5,850
$75.34 P/Share
|
|
Jan 19
2022
|
Jonathan Elliott Dickinson EVP, General Manager, Europe |
BUY
Grant, award, or other acquisition
|
Direct |
6,959
+15.59%
|
-
|
|
Jan 19
2022
|
Michael James Morrissey EVP, Head of Tech. Operations |
BUY
Grant, award, or other acquisition
|
Direct |
6,959
+11.11%
|
-
|
|
Jan 18
2022
|
Jonathan Elliott Dickinson EVP, General Manager, Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
202
-0.33%
|
$15,150
$75.01 P/Share
|
|
Jan 18
2022
|
Michael James Morrissey EVP, Head of Tech. Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
202
-0.21%
|
$15,150
$75.01 P/Share
|
|
Jan 07
2022
|
Paula J Swain EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
10,870
-13.06%
|
$793,510
$73.31 P/Share
|
|
Jan 07
2022
|
Paula J Swain EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
10,870
+11.55%
|
$793,510
$73.21 P/Share
|
|
Jan 04
2022
|
Jonathan Elliott Dickinson EVP, General Manager, Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
136
-0.44%
|
$9,656
$71.81 P/Share
|
|
Jan 04
2022
|
Michael James Morrissey EVP, Head of Tech. Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
136
-0.28%
|
$9,656
$71.81 P/Share
|
|
Jan 04
2022
|
Paula J Swain EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
9,319
-11.41%
|
$680,287
$73.46 P/Share
|
|
Jan 04
2022
|
Paula J Swain EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
9,319
+10.24%
|
$680,287
$73.21 P/Share
|
|
Jan 03
2022
|
Paul Trower Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
8,214
-10.8%
|
$599,622
$73.31 P/Share
|
|
Jan 03
2022
|
Paul Trower Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,214
+9.42%
|
$599,622
$73.21 P/Share
|
|
Jan 01
2022
|
Dashyant Dhanak EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,678
+17.08%
|
-
|
|
Jan 01
2022
|
Jonathan Elliott Dickinson EVP, General Manager, Europe |
BUY
Grant, award, or other acquisition
|
Direct |
3,615
+10.43%
|
-
|
|
Jan 01
2022
|
Barry P Flannelly EVP & General Manager US |
BUY
Grant, award, or other acquisition
|
Direct |
8,678
+11.42%
|
-
|
|
Jan 01
2022
|
Vijay K Iyengar EVP, GMAPPS |
BUY
Grant, award, or other acquisition
|
Direct |
8,678
+18.43%
|
-
|
|
Jan 01
2022
|
Michael James Morrissey EVP, Head of Tech. Operations |
BUY
Grant, award, or other acquisition
|
Direct |
3,615
+6.86%
|
-
|
|
Jan 01
2022
|
Maria E Pasquale EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
14,463
+21.26%
|
-
|
|
Jan 01
2022
|
Christiana Stamoulis EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,463
+20.11%
|
-
|
|
Jan 01
2022
|
Steven H Stein EVP & Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,926
+17.77%
|
-
|
|
Jan 01
2022
|
Paula J Swain EVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
8,678
+10.71%
|
-
|